Synaptic changes characterize early behavioural signs in the ME7 model of murine prion disease

The European Journal of Neuroscience
Colm CunninghamV Hugh Perry

Abstract

Prion diseases are fatal, chronic neurodegenerative diseases of mammals, characterized by amyloid deposition, astrogliosis, microglial activation, tissue vacuolation and neuronal loss. In the ME7 model of prion disease in the C57BL/6 J mouse, we have shown previously that these animals display behavioural changes that indicate the onset of neuronal dysfunction. The current study examines the neuropathological correlates of these early behavioural changes. After injection of ME7-infected homogenate into the dorsal hippocampus, we found statistically significant impairment of burrowing, nesting and glucose consumption, and increased open field activity at 13 weeks. At this time, microglia activation and PrPSc deposition was visible selectively throughout the limbic system, including the hippocampus, entorhinal cortex, medial and lateral septum, mamillary bodies, dorsal thalamus and, to a lesser degree, in regions of the brainstem. No increase in apoptosis or neuronal cell loss was detectable at this time, while in animals at 19 weeks postinjection there was 40% neuronal loss from CA1. There was a statistically significant reduction in synaptophysin staining in the stratum radiatum of the CA1 at 13 weeks indicating loss of presyna...Continue Reading

References

Jul 1, 1979·Maryland State Medical Journal·J Rubin
Aug 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·A TaraboulosS B Prusiner
Jun 1, 1988·Trends in Neurosciences·V H Perry, S Gordon
Jan 1, 1986·Physiology & Behavior·A J HunterR H Kimberlin
Jul 1, 1995·Brain Pathology·A GieseH A Kretzschmar
Oct 6, 1995·Neuroscience Letters·P J LucassenH Fraser
Aug 1, 1996·Trends in Neurosciences·G W Kreutzberg
Apr 1, 1997·Experimental Neurology·A WilliamsM Bruce
Dec 16, 1998·Neurobiology of Disease·A R JohnstonN MacLeod
Jun 7, 2000·Neuropathology and Applied Neurobiology·P V BelichenkoJ R Fraser
Jul 4, 2001·Neuroreport·R M DeaconJ N Rawlins
Sep 13, 2001·The European Journal of Neuroscience·K GuentherJ N Rawlins
May 9, 2002·Behavioural Brain Research·Robert M J DeaconJ Nicholas P Rawlins
May 16, 2002·Acta Neuropathologica·S SisóI Ferrer

❮ Previous
Next ❯

Citations

Jan 24, 2007·Mammalian Genome : Official Journal of the International Mammalian Genome Society·Ane Marcos-CarcavillaMagdalena Serrano
Jan 13, 2005·Acta Neuropathologica·Ursula UnterbergerHerbert Budka
Jul 21, 2010·Acta Neuropathologica·V Hugh Perry
Nov 28, 2007·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Matthew J BellizziHarris A Gelbard
Sep 21, 2011·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Colm Cunningham, Donal Thomas Skelly
Aug 1, 2009·Neurotoxicity Research·Clive BateAlun Williams
May 25, 2012·Nature·Julie A MorenoGiovanna R Mallucci
Apr 5, 2007·Nature Protocols·Robert M J Deacon
Jan 16, 2007·Nature Reviews. Immunology·V Hugh PerryClive Holmes
Jan 21, 2012·The Journal of Biological Chemistry·Clive Bate, Alun Williams
Aug 19, 2011·Pancreas·Alexander StromFraser W Scott
Mar 24, 2009·Annual Review of Immunology·Richard M Ransohoff, V Hugh Perry
Apr 9, 2010·Molecular Neurodegeneration·Clive BateAlun Williams
Jun 14, 2012·PloS One·Yoshifumi IwamaruHiroshi Kitani
Dec 5, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Roberto ChiesaDavid A Harris
Jan 20, 2012·Journal of Visualized Experiments : JoVE·Robert Deacon
Dec 27, 2013·International Journal of Cell Biology·Assunta SenatoreRoberto Chiesa
Dec 25, 2004·Proceedings of the National Academy of Sciences of the United States of America·Roberto ChiesaDavid A Harris
Jan 7, 2014·Neural Plasticity·Zuzana Šišková, Marie-Ève Tremblay
Feb 15, 2014·Journal of Neuroscience Methods·Paulin Jirkof
Apr 12, 2014·Human Molecular Genetics·Susan W RobinsonJoern R Steinert
Jun 20, 2014·Brain : a Journal of Neurology·Diego Gomez-NicolaV Hugh Perry
Feb 19, 2011·International Journal of Alzheimer's Disease·Fiorella Malchiodi-AlbediMarco Diociaiuti
Jul 18, 2008·Proceedings of the National Academy of Sciences of the United States of America·Melanie D WhiteGiovanna R Mallucci
Sep 21, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Éadaoin W GriffinColm Cunningham
Oct 11, 2011·Cellular and Molecular Life Sciences : CMLS·Rafael LindenLuis Mauricio T R Lima
Jan 16, 2016·International Journal of Molecular Sciences·Abigail B DiackJean C Manson
Mar 18, 2008·Journal of Neuropathology and Experimental Neurology·Sarah L FranklinSamar Betmouni
Oct 29, 2004·The American Journal of Pathology·Hyoung-Gon LeeGeorge Perry

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amygdala: Sensory Processes

Amygdalae, nuclei clusters located in the temporal lobe of the brain, play a role in memory, emotional responses, and decision-making. Here is the latest research on sensory processes in the amygdala.

Astrocytes & Amyloid

Astrocytes are thought to play a role in amyloid production and have been implicated in neurodegenerative diseases such as Alzheimer’s disease. Here is the latest research on the relationship between astrocytes and amyloid.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Astrocytes & Neurodegeneration

Astrocytes are important for the health and function of the central nervous system. When these cells stop functioning properly, either through gain of function or loss of homeostatic controls, neurodegenerative diseases can occur. Here is the latest research on astrocytes and neurodegeneration.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis